A retrospective study in coronary artery bypass graft patients was undertaken to assess the effect of gentamicin and a bypass prime with a high calcium on the incidence of renal failure. Patients who received both Haemaccel (polygeline, Hoechst Marion Roussel) (calcium concentration 6.25 mmol/l) in the bypass prime and gentamicin perioperatively had a higher incidence of renal failure compared with those who received only Haemaccel (P=0.005), only gentamicin (P=0.002) or neither (P=0.0001). We suggest that the combination be avoided in this group of patients.
The incidence of acute renal failure in cardiac surgical patients is approximately 3-5% 1 . Known risk factors include preoperative renal impairment, chronic cardiac failure, age extremes, prolonged cardiopulmonary bypass and perioperative low cardiac output. While the incidence of renal failure in elective coronary artery bypass graft (CABG) patients should be less than 1% 2 , when it does occur, morbidity and mortality are high. In such patients, acute renal failure requiring dialysis is associated with a 50% incidence of subsequent hospital death 3 . We noted that the incidence of renal failure in one of our units was considerably higher than in another unit (in another hospital) despite the fact that the consultant medical practitioners involved in anaesthesia, perfusion, surgery and intensive care were the same. A review of the practices in both units revealed that the only differences in management related to: -antibiotic prophylaxis and -bypass prime content.
We hypothesized that the presence of a high calcium content in the bypass prime would potentiate aminoglycoside nephrotoxicity in a group of patients who sustained an ischaemia/reperfusion type injury to the kidney. A retrospective study was undertaken to assess the incidence and severity of renal failure in four groups of patients who had been managed differently with respect to antibiotic prophylaxis and bypass prime content.
PATIENTS AND METHODS
The medical records of four groups of patients who had undergone elective coronary artery bypass graft (CABG) surgery in the two hospitals were examined. The differences in management between the four groups with respect to antibiotic prophylaxis and bypass prime are detailed in Table 1 . Haemaccel (polygeline, Hoechst Marion Roussel) one litre (calcium concentration 6.25 mmol/l) was used in Groups A and B. Crystalloid-Hartmann's solution or Ringers injection (calcium concentration 2 mmol/l) was used to make up the rest of the prime volume of two litres. Groups C and D received only crystalloid (no Haemaccel) in the prime. Albumin 100 ml was used in Groups B and D.
Two of the Groups (A and C) received gentamicin 1.5 mg/kg on induction and eight-hourly for 24 hours and flucloxacillin 3 g intraoperatively and 1 g six- Management of anaesthesia and cardiopulmonary bypass was conducted in a similar fashion for each group. Hypothermic (28°C) non-pulsatile cardiopulmonary bypass with membrane oxygenation and alpha stat blood gas management was used. Bypass in all patients was conducted with a flow rate of 2.4 l/min/m 2 at normothermia and decreased to 1.5 l/min/m 2 with hypothermia. However, mixed venous oxygen saturation was monitored and blood flow increased above those parameters if necessary, to maintain at least 75% saturation. Mean arterial pressure was maintained at 55-60 mmHg with incremental doses of vasoconstrictors (phenylephrine or noradrenaline) when necessary.
Measurement and Statistical Analysis
Clinically important acute renal failure 4 was defined as an increase of >50% in the serum creatinine on the first postoperative day in those patients whose creatinine was also >120 µmol/l. Measurement of the serum creatinine was performed by the two laboratories in the two hospitals in identical fashion, using the Jaffe reaction 5 .
The results were analysed using a Chi squared test for categorical values. Analysis of variance was used to test for differences between means with post hoc comparison by Scheffe's procedure. A value of P<0.05 was regarded as significant.
RESULTS
There was no significant difference between the four groups with respect to age and bypass times ( Table 2) . Preoperatively, all patients had a normal serum creatinine (<120 µmol/l) and the mean creatinine levels for each group were similar ( Table  2 ). There was no significant difference with respect to calcium channel blocker use ( Table 2 ). There was no difference between any of the medical practitioners involved with respect to antibiotic and prime use.
The incidence of renal failure within each group can be seen in Figure 1 . In Group A (Haemaccel and gentamicin), 31% of patients (28/91) developed renal failure compared with 12% (9/72) in Group B (Haemaccel and cephalothin), 7% (4/57) in Group C (crystalloid and gentamicin) and 2% (1/47) in Group D (crystalloid and cephalothin). The combination of Haemaccel and gentamicin gave rise to a significantly greater incidence of acute renal impairment than each of the other groups. A v B, P=0.005; A v C, P=0.002; A v D, P=0.0001.
There was no significant difference between Haemaccel alone (Group B) vs gentamicin (Group C), both groups producing a similar incidence of renal failure. Group B (Haemaccel) had a greater incidence of renal impairment than Group D (neither Haemaccel nor gentamicin) (P=0.005). Group C (gentamicin) however, did not differ significantly from Group D.
The mean preoperative creatinine levels were similar (Table 2 and Figure 2 
DISCUSSION
This study has demonstrated that the combination of a Haemaccel prime with a high calcium concentra-648 M. SCHNEIDER, S. VALENTINE ET AL Anaesthesia and Intensive Care, Vol. 24, No. 6, December 1996 tion and gentamicin might result in renal impairment. Haemaccel without gentamicin resulted in a lower incidence of renal failure, although gentamicin alone did not produce a significant insult. Hypothermic non-pulsatile cardiopulmonary bypass is associated with a decrease in global renal perfusion. An ischaemia/reperfusion type injury occurs with bypass and re-establishment of pulsatile flow to the renovascular bed 6 . Gentamicin-associated nephrotoxicity occurs predominantly at the proximal tubular level. The drug is concentrated in the renal cortex and taken up by proximal tubular cells 7 . After binding to the proximal tubes, it is incorporated into the cell in microvesicles. There is alteration in the structure and function of subcellular organelles, with the enhancement of renal cortical mitochondrial generation of reactive oxygen metabolites 8 . It has also been demonstrated that gentamicin exacerbates post-ischaemic acute renal failure by adversely influencing the reperfusion process 9 . Ischaemia may predispose to outer medullary drug uptake, imposing a nephrotoxic burden on sublethally damaged proximal tubules. Those patients who received gentamicin were also given flucloxacillin. While flucloxacillin can rarely produce an interstitial nephritis, it is not a common nephrotoxic agent. Cephalothin can falsely elevate the serum creatinine 10 , possibly explaining the rise seen in Group D (although not significant) ( Figure 2) .
Ischaemia/reperfusion injury is mediated at least partly by oxygen free radicals, the sources of which are leucocyte activation and lipid peroxidation which are known to occur during cardiopulmonary bypass 11 .
Calcium plays a vital role in the reperfusion period, potentiating the damaging effects of oxygen free radicals on renal mitochondria. The potential for calcium to play a major role in cell injury has long been suspected. It is known that tissue calcium levels increase when lethal cell injury develops and that this is predominantly due to mitochondrial accumulation and sequestration. Weinberg 12 has shown in an aminoglycoside induced model of nephrotoxicity that there is a consistent pattern of calcium uptake and resultant functional change in renal cortical mitochondria. Using mitochondrial isolation techniques, he was able to demonstrate uptake of calcium and subsequent damage prior to cell necrosis. Thus, a possible cause-effect relationship has been established rather than merely an epiphenomenon of calcium entering cells that have already undergone necrosis.
Haemaccel, a urea linked gelatin colloid, has a calcium concentration of 6.25 mmol/l. When present in a bypass prime, it would be delivered directly and rapidly to the arterial renovascular bed at a time of onset of renal ischaemia. Skelly et al 13 demonstrated a significant rise in plasma ionised calcium (Ca ++ ) when Haemaccel was used in a pump prime. There was also a persistent elevation in Ca ++ during the reperfusion phase. The other components of Haemaccel including polygeline, sodium, potassium, chloride, phosphate and polypeptides are not known nephrotoxic agents.
Hypercalcaemia has been shown to potentiate aminoglycoside-induced nephrotoxicity in a number of animal models 14, 15 . The mechanism of this action is complex and poorly understood. Hypercalcaemia without an accompanying nephrotoxic injury will not exert a deleterious effect on the kidney. However, with an accompanying gentamicin-induced lesion at the renal tubular membrane level, potentiation of nephrotoxicity will occur. Elliott et al 15 compared gentamicin nephrotoxicity in parathyroid hormone stimulated rates with parathyroidectomized rats. The parathyroid hormone stimulated animals had significantly higher serum ionized calcium concentrations, higher peak renal cortical gentamicin concentrations and higher serum creatinine concentrations. They postulated that increased nephrotoxicity might be caused by increased calcium influx into gentamicininjured proximal tubular cells.
Any retrospective study has obvious limitations. Such studies are prone to confounding effects and subject to bias because of their uncontrolled and non-randomized nature. We were not able in this study to assess other factors which may influence postoperative renal function, e.g. postoperative 649 ACUTE RENAL FAILURE IN haemodynamics and use of inotropes. The dose of vasoconstrictor during bypass was not accurately recorded and therefore could not be studied. However, vasoconstrictor use during bypass has not been shown to have an adverse effect on renal function 16 . In particular, a retrospective study investigating renal impairment has limitations as serum creatinine values can be a poor indicator of renal function. However, a number of studies (including prospective ones) 4, 17 have used the percentage change in serum creatinine as a reliable indicator of renal dysfunction. In this way the effect of muscle bulk on absolute creatinine level is minimized by comparing the change in creatinine level of each patient group.
In conclusion, there is experimental work to support the damaging role that hypercalcaemia plays in aminoglycoside-induced nephrotoxicity. To our knowledge this is the first clinical study to confirm this. It must be emphasized that both the hypercalcaemia and the gentamicin were imposed on an already injured kidney in the form of a reperfusion injury. However, the group that did not receive either Haemaccel or gentamicin sustained a low (2%) incidence of renal failure, suggesting that the possible reperfusion injury alone was not a clinically significant insult. We suggest avoiding the combination of high-calcium-containing primes and aminoglycoside antibiotics in patients undergoing cardiac surgery. The manufacturers suggest that rapid infusion of Haemaccel intravenously can result in transient hypercalcaemia. This might have adverse renal consequences in certain conditions such as shock when aminoglycosides are also administered.
